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Abstract
Here we investigated the role of the Nod/Rip2 pathway in host responses to Chlamydophila pneumoniae–induced
pneumonia in mice. Rip2
2/2 mice infected with C. pneumoniae exhibited impaired iNOS expression and NO production, and
delayed neutrophil recruitment to the lungs. Levels of IL-6 and IFN-c levels as well as KC and MIP-2 levels in bronchoalveolar
lavage fluid (BALF) were significantly decreased in Rip2
2/2 mice compared to wild-type (WT) mice at day 3. Rip2
2/2 mice
showed significant delay in bacterial clearance from the lungs and developed more severe and chronic lung inflammation
that continued even on day 35 and led to increased mortality, whereas WT mice cleared the bacterial load, recovered from
acute pneumonia, and survived. Both Nod1
2/2 and Nod2
2/2 mice also showed delayed bacterial clearance, suggesting that
C. pneumoniae is recognized by both of these intracellular receptors. Bone marrow chimera experiments demonstrated that
Rip2 in BM-derived cells rather than non-hematopoietic stromal cells played a key role in host responses in the lungs and
clearance of C. pneumoniae. Furthermore, adoptive transfer of WT macrophages intratracheally was able to rescue the
bacterial clearance defect in Rip2
2/2 mice. These results demonstrate that in addition to the TLR/MyD88 pathway, the Nod/
Rip2 signaling pathway also plays a significant role in intracellular recognition, innate immune host responses, and
ultimately has a decisive impact on clearance of C. pneumoniae from the lungs and survival of the infectious challenge.
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Introduction
Chlamydophila pneumoniae is a Gram-negative obligate intracellu-
lar pathogen that is widely prevalent [1], causes respiratory tract
diseases such as pneumonia, sinusitis, and bronchitis, contributes
to acceleration of atherosclerosis [2,3], and is associated with
development of chronic lung diseases such as asthma [4] and other
disorders where chronic inflammation is a hallmark feature [5,6].
C. pneumoniae infects various cell types such as epithelial cells,
monocytes, macrophages, smooth-muscle cells and endothelial
cells, and often resides intracellularly for indefinite periods [7].
C. pneumoniae induces a similar lung pathology in humans and
rodents [8]. A mouse model of lung infection has been used to
study the immunological mechanisms of host defenses. Host
immune responses to C. pneumoniae proceeds in two stages; 1) an
early response requiring IFN-c to limit the growth of the
intracellular bacteria, which plays a central role in the innate
control of this infection, and 2) a later adaptive immune response
that includes CD4
+ and CD8
+ T cells in bacterial clearance and
protection [9–11]. While the primary immune response is aimed
to clear the primary infection from the host and provide protection
against reinfection with the same pathogen, generation of tissue
injury also occurs and Chlamydial infections often recur or remain
persistent and long-term consequences of recurrent or persistent
chlamydial infections can be severe [10,12].
Chlamydia is internalized by macrophages as well as by ‘‘non-
professional’’ phagocytes, where it survives and replicates. C.
pneumoniae elicits IFN-c production in infected bone marrow-
derived macrophages [13]. In such cells, IFN-c synergizes with
bacterial products to activate various bactericidal mechanisms,
including inducible nitric oxide synthase (iNOS), which leads to
production of NO [14,15], which in turn inhibits chlamydial
growth [14,16,17].
Molecular motifs derived from C. pneumoniae are detected by
several pattern recognition receptors, especially Toll-like receptor
2 (TLR2) and TLR4 [18,19]. TLR4 recognizes chlamydial
components such as lipopolysaccharide (LPS) and heat shock
protein 60 (cHSP60) [20–24], and the intact organism stimulates
TLR2 and TLR4-mediated responses [25,26]. TLR-mediated
signaling triggered by C. pneumoniae-derived molecules instigates
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TLR/MyD88 signaling plays an important role in host responses
against C. pneumoniae infection [18,19]. Studies from our laboratory
indicate that MyD88-null mice with C. pneumoniae lung infections
are unable to mount a sufficient early inflammatory response
against the pathogen [18]. These mice show marked delays in
recruiting PMNs, CD8+ and CD4+ T cells to the lungs, and fail to
clear the pathogen, but then develop a severe, late-stage, and
persistent inflammation characterized by increased IL-1b and
IFN-c production that leads to increased mortality [18]. In
contrast, TLR4
2/2, TLR2
2/2, and WT mice—all of which can
detect C. pneumoniae and can signal normally via MyD88, readily
recovered from the infection and cleared bacteria normally,
indicating that MyD88 is essential to an effective defense, but that
TLR2 and TLR4 can both detect the pathogen and are therefore
redundant [18,19].
C. pneumoniae has a unique biphasic developmental cycle that
occurs within the chlamydial inclusion, a membrane-bound
vacuole that is trafficked to the peri-Golgi region, where it avoids
fusion with lysosomes and destruction, and are able to replicate
intracellularly [27,28]. Chlamydia-mediated vesicular trafficking
events transform the inclusion into a compartment from which
chlamydiae can acquire nutrients and interfere with multiple host
cell functions [29,30]. While residing intracellularly, the pathogen
presumably is not detected by the cell surface TLR2 and TLR4
receptors; hence, it is unclear how C. pneumoniae might be detected
and held in check once it has been taken up by the cell. C.
pneumoniae–infected macrophages can limit bacterial growth by
expression of IFN-c, which in turn is controlled by TLR4/
MyD88-dependent pathway. However, since Chlamydia can also
induce IFN-c in the absence of TLR4/MyD88 signaling [31], a
potential role for TLR-independent and intracellular recognition
receptors, such as the nucleotide oligomerization domain (Nod)
proteins, has been suggested [31].
Nod proteins and their adaptor molecule Rip2 also known as
RICK or CARDIAK are key components of a family of cytosolic
innate immune pattern recognition receptors [32–36]. Nod1 and
Nod2 recognize molecules in the cytoplasm that originate from
bacteria, including peptidoglycan (PGN), a component of bacterial
cell walls, and the muramyl dipeptide (MDP) structure found in
almost all bacteria [37]. Both Nod1 and Nod2 signal via the
serine/threonine Rip2 kinase [34,38,39]. Once activated, Rip2
mediates activation of NF-kB and the subsequent production of
inflammatory cytokines such as TNF-a and IL-6 [40–42].
Although some reports indicate that Nod/Rip2-mediated signal-
ing does not induce IFN-c [43], other studies show that combined
TLR and Nod/Rip2 signaling together can lead to IFN-c
expression [44].
In the present study we show that the Nod/Rip2 signaling
pathway is essential to detect intracellular C. pneumoniae and direct
subsequent innate immune host defenses and bacterial clearance
in a mouse model of pneumonia, in addition to the well-
established role of the TLR/MyD88 pathway. Rip2
2/2 mice
infected with C. pneumoniae displayed an impaired cytokine and
chemokine release such as IFN-c, KC and MIP2, and showed
impaired iNOS mRNA expression and NO production, and
delayed neutrophil recruitment, which led to delayed bacterial
clearance, an intense late-stage and persistent lung inflammation
and increased mortality.
Results
Rip2
2/2 mice develop severe and persistent
histopathologic lung inflammation following C.
pneumoniae infection compared to WT mice
Rip2
2/2 mice and WT controls were infected intratracheally
with C. pneumoniae (1610
6 IFU/mouse) and evaluated for lung
inflammation by histopathological analysis. Tissue sections were
obtained at 3, 5, 14, and 35 days after infection, fixation and
histological staining (H&E) was performed, and sections were
graded for degree of inflammation in blinded fashion as detailed in
the Materials and Methods Section. As expected, C. pneumoniae–
infected WT mice developed marked lung inflammation as
expected by days 5 and 14 and cleared the inflammation and
recovered to baseline by day 35 (Figure 1A and 1B). However,
Rip2
2/2 mice developed significantly greater lung inflammation
than WT mice by day 5, and day 14, which persisted until the end
of the study period at day 35 (Figure 1A and 1B).
Rip2 deficiency impairs the production of inflammatory
cytokines during C. pneumoniae infection by day 3
Innate immune responses, and particularly IFN-c plays an
important role in host defense against acute infection and in
establishment of persistence of C. pneumoniae [10]. We, therefore,
determined the production of cytokines such as IL-6, IL-12 p40
and IFN-c levels in BALF and lung homogenates from infected
Rip2
2/2 and WT mice on days 3, 5 and 14. Concentrations of IL-
6, IL-12p40, and IFN-c were significantly reduced in BALF of
Rip2
2/2 mice at day 3 compared to WT mice (Figure 1C).
However, by day 5 and day 14, IL-6, IL-12p40 and IFN-c
concentrations in the BALF and lung homogenates from Rip2
2/2
mice were significantly increased and exceeded levels in WT mice
(Figure 1C). Thus, in addition to increased histopathological
inflammation seen in Rip2
2/2 mice on days 5 and 14 and during
the later stages, we observed an initial impaired and delayed
kinetics in cytokine production in C. pneumoniae–infected Rip2
2/2
Author Summary
Chlamydophila pneumoniae (C. pneumoniae) is a common
intracellular parasite that causes lung infections and
contributes to several diseases characterized by chronic
inflammation. Toll-like receptors expressed on the cell
surface detect C. pneumoniae and mount a vigorous
defense, but it is not known how the cell defends itself
once the pathogen has taken up residence as a parasite.
We reasoned that cytosolic pattern recognition receptors
called Nods (nucleotide oligomerization domain) that
detect microbes that gain entry into the cell might be
involved. Using mice genetically deficient in Nod1 and
Nod2 or their common downstream adaptor (Rip2), we
show that in lung infection, Nod proteins are indeed
essential in directing a defense against C. pneumoniae.
Mice with defective Nod/Rip2-dependent signaling exhib-
ited delayed recruitment of neutrophils, blunted produc-
tion of pro-inflammatory cytokines and chemokines, and
evidence of defective iNOS expression and NO production.
These impaired responses led to delayed clearance of
bacteria, intense persistent lung inflammation, and in-
creased mortality. By performing bone marrow transplan-
tation experiments and direct transfer of cells into the
lungs of mice, we demonstrated that intact Nod-depen-
dent signaling in bone marrow–derived cells was critical in
the defense against C. pneumoniae. Our results indicate
that Nod proteins also play an important role in host
defense against C. pneumoniae. Coordinated and sequen-
tial activation of TLR and Nod signaling pathways may be
necessary for an efficient immune response and host
defense against C. pneumoniae.
NOD/RIP2 in Chlamydophila pneumoniae Infection
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in cytokine production in the lungs on days 5 and 14 (Figure 1C).
We next measured IL-6 and IFN-c levels in the supernatant of
infected bone marrow–derived macrophages (BMDM) and whole
lung cells ex-vivo. C. pneumoniae infection-induced cytokine produc-
tion ex-vivo (IL-6, and IFN-c release) were significantly impaired in
both Rip2
2/2 macrophages and whole lung cells compared to
WT macrophages and whole lung cells (Figure S1A–S1D).
Figure 1. Rip2
2/2 mice develop a severe and chronic lung inflammation and manifest impaired early cytokine production in
response to C. pneumoniae infection. WT and Rip2
2/2 mice were infected with C. pneumoniae (1610
6 IFU/mouse). Lungs of infected mice were
isolated on days 3, 5, 14, and 35 after infection. Lungs were fixed in 10% buffered formalin, sectioned, and stained with H&E to determine the extent
of inflammation (A). Histological analysis of inflammation in C. pneumoniae–infected lungs of WT and Rip2
2/2 mice on days 3, 5, 14, and 35 post-
infection (B). Statistical significance was determined by Student’s t test (*p,0.05, **p,0.01, ***p,0.001). At 3, 5, and 14 days post-infection, the
levels of IL-6, IL-12p40, and IFN-c in BALF and lung tissue homogenates were determined (C). Statistical significance was determined by Student’s t
test (*p,0.05, n=8–14).
doi:10.1371/journal.ppat.1000379.g001
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2/2 mice show delayed
bacterial clearance from the lungs and increased
mortality
Our data show impaired cytokine production in Rip2
2/2 mice
infected with C. pneumoniae early on day 3 following infection but a
significant reversal and increase in cytokines and more severe and
persistent lung inflammation by day 5 and 14 compared to WT
mice (Figure 1). We hypothesized that this more severe and
persistent lung inflammation was due to an inability of Rip2
2/2
mice to clear bacteria, which would then be expected to continue
to provoke inflammation and cause the delayed increase in
cytokine production. To test this hypothesis, we performed
quantitative bacterial cultures in the lungs of mice at days 3, 5,
and 14 post-infection. As anticipated, we observed significantly
higher numbers of C. pneumoniae IFU in the lungs of Rip2
2/2 mice
on days 5 and 14 compared to WT mice (Figure 2A). This could
not be explained by higher baseline load of bacteria in Rip2
2/2
mice, since on day 3, bacterial numbers in lungs were similar
between WT and Rip2-deficient mice (Figure 2A). Consistent with
the bacterial clearance data, virtually all WT mice survived the
infectious challenge, while Rip2
2/2 mice had significantly
increased mortality, and less than half the Rip2
2/2 mice survived
until the end of the experiment at day 35 (Figure 2B).
Furthermore, the lungs from the Rip2
2/2 mice that succumbed
to infection harbored an abundance of C. pneumoniae (data not
shown), while those who survived cleared the bacteria but still
manifested chronic lung inflammation at day 35 (Figure 1B).
Collectively then, these data indicate that: 1) Rip2 importantly
contributes to clearance of C. pneumoniae from the lungs; and 2) in
the absence of Rip2, severe lung inflammation occurs and persists,
but fails to effectively combat the infection.
Rip2 deficiency impairs early neutrophil recruitment and
chemokine expression in the lungs during C. pneumoniae
infection
Polymorphonuclear neutrophils (PMN) are crucial for innate
host defense against bacteria and fungi. We previously reported
that MyD88
2/2 mice infected with C. pneumoniae fails to recruit
PMN into the lungs during early and late stages of the infection
[18]. To investigate the PMN recruitment in Rip2-deficient mice,
we infected Rip2
2/2 and WT mice with C. pneumoniae intratra-
cheally, and compared total cells and PMN in BALF on day 3 and
5 following infection. Both PMN and total BALF cells in Rip2
2/2
mice were significantly lower compared to WT mice on day 3
following infection (Figure 3A and 3B). However, by days 5 and
day 14 post-infection, PMN as well as total BALF cell counts in
Rip2
2/2 mice increased markedly, and were significantly higher
than in WT mice (Figure 3A and 3B). Assessment of neutrophil
recruitment to the lung by flow cytometric analysis demonstrated
similar results (Figure 3C). The percentage of neutrophils (defined
by Gr1+ CD11b+ cells) in the lungs of Rip2
2/2 mice were
reduced on day 3 of infection, but increased thereafter, and by
days 5 and 14, significantly exceeded the neutrophil percentage of
lung cells in WT mice (Figure 3C). We next sought to examine
whether the chemokines associated with neutrophil recruitment in
the lungs were also affected in the Rip2-deficient mice. Rip2
2/2
mice showed significantly lower concentrations of KC and MIP-2
in both BALF and lung homogenates compared with WT mice on
day 3 after infection (Figure 3D). However, both KC and MIP-2
levels in BALF and lung homogenates significantly increased in
Rip2
2/2 mice compared to WT mice by day 5 (Figure 3D).
Collectively, these data indicate that Rip2 plays an important role
in early cytokine and chemokine production and neutrophil
recruitment to the lungs during the initial days after C. pneumoniae
infection, and Rip2-deficiency leads to delayed bacterial clearance,
which is followed by an exaggerated secondary response consisting
of increased cytokine and chemokine expression, PMN recruit-
ment, prolonged, severe histopathological inflammation in the
lungs, and increased mortality.
C. pneumoniae is predominantly localized in lung
macrophages and PMNs in Rip2-deficient mice
Alveolar epithelial cells are the main cells infected in lung
infection model [45], but C. pneumoniae also infects different cell
types including macrophages, dendritic cells, endothelial cells, and
PMNs [7]. To determine which cells in the lungs are infected by C.
pneumoniae, we analyzed infected cell profiles by flow cytometry. C.
pneumoniae was predominantly found in macrophages and neutro-
phils, but also in alveolar epithelial cells in the infected lungs
(Figure 4A and 4B). Interestingly, in Rip2
2/2 mice, the number of
neutrophils that contained C. pneumoniae was significantly increased
compared to that in WT mice (Figure 4A). To address whether
more bacteria are in Rip2
2/2 macrophages and neutrophils, we
analyzed mean fluorescence intensity (MFI) per cells, which
corresponds to relative bacterial number (Figure 4C). We observed
a shifted histogram in Rip2
2/2 neutrophils. These data revealed
that neutrophils are likely the main site of Chlamydial replication
in lungs at day 5 after infection in Rip2
2/2 mice.
Figure 2. Delayed clearance of C. pneumoniae and increased mortality in Rip2
2/2 mice. WT and Rip2
2/2 mice were infected with C.
pneumoniae (1610
6 IFU/mouse). At 3, 5, and 14 days post-infection, the bacterial burden in lung tissue homogenates was determined (A). Statistical
significance was determined by Student’s t test (*p,0.05, **p,0.01). Mortality was monitored after infection (B). Statistical significance was
determined by Fisher’s exact test (*p,0.05, n=11).
doi:10.1371/journal.ppat.1000379.g002
NOD/RIP2 in Chlamydophila pneumoniae Infection
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2/2 mice is associated
with impaired ability to induce iNOS mRNA expression
and NO production
We hypothesized that a bactericidal factor produced by immune
effector cells might be responsible for the failure of Rip2
2/2 mice
to clear bacteria. NO produced after cell activation by IFN-c is
important for killing or inhibiting growth of microorganisms [46].
Both IFN-c and iNOS play major roles in host resistance to
chlamydial infection [10]. We therefore assessed the levels of
iNOS in the lungs following C. pneumoniae infection. Rip2
2/2 mice
demonstrated significantly impaired iNOS mRNA expression
compared to WT mice from day 0 until day 5 in total lung cells
examined ex vivo (Figure 5A). In addition, bone marrow-derived
macrophages obtained from Rip2
2/2 mice, showed significantly
diminished NO production following in vitro infection with C.
pneumoniae compared to WT macrophages (Figure 5B). These
results suggest that NO production plays a role in killing and
clearance of C. pneumoniae, and also suggest that Rip2 signaling
contributes to NO production in response to C. pneumoniae
infection. Consistent with this interpretation, C. pneumoniae growth
was significantly increased in WT macrophages in the presence of
an iNOS inhibitor (L-NMMA) compared to control cells treated
with an inactive form of the inhibitor (D-NMMA) (Figure 5C). In
contrast, C. pneumoniae growth was not affected by treatment with
the iNOS inhibitor in Rip2
2/2 macrophages (Figure 5C).
Collectively, these results suggest that Rip2-deficient mice have
impaired iNOS expression and NO production in response to C.
pneumoniae infection, which likely contribute to the host immune
response defect and delayed bacterial clearance from the lungs of
Rip2
2/2 mice.
Both Nod1 and Nod2 recognize intracellular C.
pneumoniae in macrophages and play an essential role in
bacterial clearance in vivo
Our results thus far indicate that the Rip2
2/2 mice display an
impaired host defenses, delayed bacterial clearance, and increased
mortality following C. pneumoniae lung infection. Since Rip2 is
utilized by both Nod1 and Nod2, we next wished to determine the
Figure 4. Identification of cell types in the lung harboring C. pneumoniae. Single cell suspensions of infected lungs (day 5) were stained with
FITC-anti-Chlamydia mAb and analyzed by flow cytometry to determine which cell types contained C. pneumoniae (A). Composition of lung
leukocytes in infected mice (day 5) (B). Statistical significance was determined by Student’s t test (*p,0.05, **p,0.01). Representative histograms
were shown to analyze relative bacterial number in macrophages (MAC) and neutrophils (Neu) between WT (thin line histogram) and Rip2
2/2 (gray-
filled histogram) (C).
doi:10.1371/journal.ppat.1000379.g004
Figure 3. Rip2 deficiency impairs early neutrophil recruitment and chemokine expression in the lungs during C. pneumoniae
infection. C. pneumoniae was inoculated intratracheally into Rip2
2/2 and WT mice (1610
6 IFU/mouse). BALF was collected from WT and Rip2
2/2
mice on days 0, 3, 5, and 14 post-infection. Total BAL cells (A) and PMN (B) were counted. Statistical significance was determined by Student’s t test
(*p,0.05, ***p,0.001, n=10,14). Lungs were removed, and digested with collagenase and DNase I. Cells were stained with PE-anti-GR1 mAB and
PECy5-anti-CD11b mAb and analyzed by FACScan (C). The percentages of gated positive cells are indicated. Data shown are representative of four
independent experiments. The levels of KC and MIP-2 in BALF and lung tissue homogenates on days 3 and 5 post-infection were determined (D).
Statistical significance was determined by Student’s t test (*p,0.05, **p,0.01, ***p,0.001).
doi:10.1371/journal.ppat.1000379.g003
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was shown to play a role in C. pneumoniae-mediated activation of
human endothelial cells in vitro [47], But it is unclear which Nod
receptors detect C. pneumoniae in macrophages and during in vivo
infection. Nod1 is ubiquitously expressed in mammalian cells, but
the expression of Nod2 is mainly restricted to primary antigen-
presenting cells and epithelial cells, and Nod2 is not expressed in
endothelial cells [48]. Furthermore, our data (Figure 4C) indicates
that C. pneumoniae mainly replicates in macrophages and
neutrophils. To determine which Nod receptor recognizes
intracellular C. pneumoniae in macrophages, we infected Nod1
2/2
or Nod2
2/2 BMDM with live C. pneumoniae and measured KC
and NO levels in the supernatant. Nod1
2/2 and Nod2
2/2
macrophages produced significantly diminished KC and NO
(Figure 6A and 6B). Consistent with this decreased NO
production, bacterial viability was significantly higher in both
Nod1
2/2 and Nod2
2/2 macrophages in vitro (Figure 6C). To
determine if greater bacterial viability in the absence of Nod1 and
Nod2 also occurred in vivo, we infected Nod1
2/2 and Nod2
2/2
mice with C. pneumoniae and examined bacterial clearance in the
lungs. In agreement with the in vitro data, both Nod1
2/2 and
Nod2
2/2 mice displayed delayed pulmonary bacterial clearance
compared to WT controls, as reflected by significantly higher
bacterial counts in Nod1
2/2 and Nod2
2/2 mice at 5 days post-
infection (Figure 6D). These results are consistent with the
conclusion that intracellular C. pneumoniae is recognized by both
Nod1 and Nod2 in macrophages, and that signaling emanating
from both Nod1 and Nod2 significantly contributes in host
defenses against C. pneumoniae lung infection, at least in part by
regulating production of NO and inflammatory cytokines and
chemokines such as IL-12 p40, IFN-c, KC and MIP2.
Rip2 in bone marrow–derived cells is important for
bacterial clearance of C. pneumoniae from the lung
Based upon data in the previous section that showed
involvement of macrophages and PMNs in the lungs, we
hypothesized that the Nod/Rip2 signaling pathway in bone
marrow (BM)-derived cells rather than non-hematopoietic stromal
cells was primarily responsible for innate immune host responses
and clearance of C. pneumoniae from the lungs. To test this notion,
we generated chimeric mice using donor marrow from WT or
Rip2
2/2 mice (Figure S2), then infected the mice intratracheally
with C. pneumoniae. Five days after infection, lungs were harvested
and quantitative bacterial counts were determined. WT recipient
mice that were transplanted with Rip2
2/2 BM displayed
significantly higher bacterial load in the lungs compared to control
WT mice transplanted with WT BM (Figure 7A). Conversely,
Rip2
2/2 recipient mice that had been transplanted with WT BM
displayed lower bacterial counts than control Rip2
2/2 mice that
had received Rip2
2/2 BM (Figure 7A). In all chimeric mice, we
observed generally higher bacterial titers observed in the lungs,
most likely due to inherently increased susceptibility secondary to
the irradiation procedure itself, as has been previously reported by
other investigators [49]. These data indicate that Rip2 in BM-
derived cells primarily mediates host defenses against pulmonary
C. pneumoniae infection. However, it is possible that airway
epithelial cells also contribute and play a role in C. pneumoniae
detection in the lung. In order to further elucidate the primary role
of macrophages in C. pneumoniae infection, we performed
intratracheal adoptive transfer of WT or Rip2
2/2 BMDM,
simultaneously with C. pneumoniae infection (i.e. macrophages
mixed with bacteria), and then determined the effect on local
bacterial replication in lungs of WT or Rip2
2/2 mice. As
Figure 5.Impaired iNOS mRNAexpression andNOproductionin Rip2
2/2 mice. Lungtissues of WTandRip2
2/2 micewere removedat days0, 1,
and5 post-infection.iNOS mRNA expression was measured by semi-quantitative RT-PCR (A). Bone marrow–derived macrophages (BMDM) were stimulated
with C. pneumoniae for 24h. NO production was evaluated by measuring nitrite accumulation in the supernatant using the Griess reaction (B). Statistical
significance was determined by Student’s t test (*p,0.01,**p,0.001, n=4). C. pneumoniae (MOI 5)–infected BMDMswerecultured in the presence of5mM
L-NMMA or D-NMMA for 5 days. Cell lysates were harvested and viable bacteria were quantified by infecting HEp2 cells (C). Statistical significance was
determined by one-way ANOVA with Tukey’s post-hoc test (*p,0.05, n=4). Data shown are representative of two independent experiments.
doi:10.1371/journal.ppat.1000379.g005
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PLoS Pathogens | www.plospathogens.org 7 April 2009 | Volume 5 | Issue 4 | e1000379Figure 7. Rip2 in BM-derived cells contributes to bacterial clearance from the lungs. BM chimeric mice were created by lethally irradiating
the recipient mice, then performing adoptive transfer and reconstitution with donor BM obtained form WT or Rip2
2/2 donor mice. After 7 weeks,
BM-reconstituted mice were infected with C. pneumoniae (1610
6 IFU). Lungs were collected on day 5 post-infection. The bacterial burden in lung
tissue homogenates was determined (A). BMDMs were grown and isolated from WT or Rip2
2/2 mice and adoptively transferred intratracheally into
the airways of WT mice or Rip2
2/2 mice (5610
5/mouse) together with C. pneumoniae (1610
6 IFU). BMDMs were first incubated with C. pneumoniae in
vitro for 30 minutes prior to intratracheal administration. After 5 days, lungs were collected and the bacterial burden in lung tissue homogenates was
determined (B). Statistical significance was determined by one-way ANOVA with Tukey’s post-hoc test (*p,0.05, n=3–5).
doi:10.1371/journal.ppat.1000379.g007
Figure 6. Chemokine and NO production in Nod1
2/2 and Nod2
2/2 BMDM and quantitative bacterial counts in lungs of Nod1
2/2
and Nod2
2/2 mice following infection with C. pneumoniae. WT, Nod1
2/2, and Nod2
2/2 BMDMs were infected with C. pneumoniae for
24 hours, and KC (A) and NO (B) concentrations in the supernatant were determined. Data shown are representative of three independent
experiments. Statistical significance was determined by Student’s t test (*p,0.05, **p,0.01, n=3–4). C. pneumoniae (MOI 5)–infected BMDM were
cultured for 5 days. Cell lysates were harvested and viable bacteria were quantified by infecting HEp2 cells (C). Data shown are representative of two
independent experiments. Statistical significance was determined by Student’s t test (*p,0.05, n=4). Nod1
2/2 and Nod2
2/2 mice were infected with
C. pneumoniae (1610
6 IFU). After 5 days, lungs were collected and the quantitative bacterial counts in lung tissue homogenates were determined (D).
Statistical significance was determined by Student’s t test (*p,0.05, **p,0.01, n=7).
doi:10.1371/journal.ppat.1000379.g006
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2/2 macrophages plus C.
pneumoniae into WT mice resulted in significantly higher bacterial
counts compared to WT macrophages plus C. pneumoniae
transferred into WT mice (Figure 7B). However, WT macrophag-
es plus C. pneumoniae adoptively transferred into Rip2
2/2 mice
rescued the Rip2 phenotype, i.e. restored bacterial clearance
(Figure 7B) and neutrophil recruitment in the lungs (Figure S3),
indistinguishable from control WT mice that received WT
macrophages plus C. pneumoniae. We did not observe a defect in
phagocytosis in Rip2
2/2 macrophages using labeled C. pneumoniae
(Figure S4) [50]. Taken together, these findings indicate that the
Nod/Rip2 signaling pathway in BM-derived cells play a dominant
role in bacterial clearance of C. pneumoniae from the lungs.
Discussion
Here we show that cytoplasmic Nod proteins are importantly
involved in generating innate immune defenses against intracel-
lular C. pneumoniae. We found that deletion of Rip2, that is essential
for both Nod1- and Nod2-mediated signaling, delays neutrophil
recruitment to the lungs, and suppresses expression of chemokines
and cytokines that are essential to generate an effective host
defense. Although an inflammatory innate immune response was
delayed, by day 5 Rip2
2/2 mice infected with C. pneumoniae
developed a more severe inflammation that persisted longer
compared to WT mice, but nevertheless failed to clear the
pathogen, and most infected Rip2
2/2 mice ultimately succumbed
to the infection. The inability of Rip2
2/2 mice to eradicate the
pathogen despite robust inflammation was associated with delayed
kinetics of IL-12p40 and IFN-c production and suppressed iNOS
expression and NO production, all of which are critically
important elements in the innate immune armamentarium
[9,11]. Experiments with bone marrow-derived macrophages
demonstrated that both Nod1 and Nod2 were involved in sensing
intracellular C. pneumoniae. Results from experiments with bone
marrow chimeric mice confirmed that cells derived from
hematopoietic lineages rather than resident stromal cells were
essential in Nod/Rip2-mediated defenses against C. pneumoniae.
This conclusion was corroborated by adoptive transfer of WT or
Rip2
2/2 macrophages directly into the airways of infected mice.
Collectively, our data demonstrate that proper functioning of the
Nod/Rip2 cytoplasmic innate immune detection system critically
determines whether the host can effectively resist and eradicate an
infectious challenge to the lungs from C. pneumoniae.
Our results underscore previous reports that increasingly
emphasize the central role Nod/Rip2 signaling can play in
defending the host against intracellular invasion. Nod proteins
mediate host defense against a variety of both Gram negative and
Gram positive bacteria. For example, Nod2 senses the PGN
produced by Staphylococcus aureus, and Rip2 limits S. aureus growth
in macrophages [51]. Also, Nod2 detects the MDP structure found
in almost all bacteria [37]. Nod1 is required for IkK and NF-kB
activation in human colon epithelial cells infected with E. coli [52],
participates in KC induction and impacts bacterial viability to
Pseudomonas aeruginosa in mouse embryonic fibroblasts [53]. Nod2
triggers cytokine production by DCs in response to live M.
tuberculosis, but is not essential to control M. tuberculosis airway
infection [54]. While Rip2 and Nod1 deficiency increases
susceptibility to Listeria monocytogenes [32] and Helicobacter pylori
[55] respectively, neither Nod1 nor Rip2 deficiency had any
significant effect on Chlamydia muridarum vaginal infection [56].
Hence, available data indicates that Nod1 and Nod2 selectively
interact with specific pathogens and can play a critical role in host
defenses, highlighted by increased susceptibility to specific
pathogens in mice lacking these intracellular receptors. Accord-
ingly, our data now indicate that Nod/Rip2 signaling is also
essential in successfully combating C. pneumoniae lung infection.
Indeed, in the absence of Nod/Rip2 signaling, lung infection with
C. pneumoniae proved fatal to the majority of mice.
Clearly, one reason for the increased susceptibility of the
Rip2
2/2 mice to C. pneumoniae lung infection may be the inability
of Rip2
2/2 mice to rapidly recruit neutrophils to the site of
infection. Delayed neutrophil recruitment in Rip2
2/2 mice
appears closely linked to lack of sufficient chemokine and cytokine
expression compared to infected WT mice. However, by days 5
and 14 post-infection, the percentage of neutrophils in the lungs of
Rip2
2/2 mice increased and significantly exceeded those in WT
mice. Evidently, this delayed early response to the infectious
challenge allows the bacteria to gain the upper hand, but despite
the significant increase in PMN numbers on days 5 and 14 post-
infection, the Rip2
2/2 mice showed delayed bacterial clearance
from the lungs and increased mortality. Interestingly, in Rip2
2/2
mice, the number of neutrophils in the lungs that contained C.
pneumoniae was significantly increased compared to that in WT
mice. Several obligate intracellular microbial pathogens develop
mechanisms to evade destruction upon ingestion by PMN [57,58].
Indeed, C. pneumoniae can infect and replicate in PMNs and these
cells in turn can enhance replication and Chlamydial burden
during infection [59].
However, the main reason Rip2
2/2 mice cannot clear the
infection and most often succumb to the disease appears to be
more closely tied to our observation that expression of IL-12p40,
IFN-c, iNOS and NO are suppressed in the absence of Rip2
2/2.
These data are consistent with previous reports, which similarly
indicate that IL-12p40 [9], IFN-c [9,60] and iNOS [11,61] are
essential for effective host resistance against C. pneumoniae infection.
Several studies showed that IFN-c and IL-12 both play an
important role in the innate control of C. pneumoniae infection
[9,11] IL-12 participates in resistance to C. pneumoniae, likely by
enhancing IFN-c mRNA [9]. In turn, IFN-c produced by innate
cells increases iNOS expression and NO release and controls the
intracellular growth of C. pneumoniae [14,16,17]. Increased
susceptibility of IFN-cR
2/2 mice is associated with diminished
levels of iNOS mRNA accumulation in lungs, and iNOS
2/2 mice
also show higher sensitivity to C. pneumoniae infection [11].
However, IFN-cR
2/2 mice shows even greater sensitivity to C.
pneumoniae infection compare to iNOS
2/2 mice, suggesting the
presence of both iNOS-dependent and -independent IFN-c-
mediated effector mechanisms [11].
IFN-c can be produced by cells from both the innate and
acquired immune system. The susceptibility of IFN-cR
2/2 mice
largely exceeds that of RAG-1
2/2 mice, suggesting an important
role for non-T cell-mediated IFN-c-producing cells in the host
resistance against C. pneumoniae infection [11]. Several studies show
that, besides NK and T cells, myeloid cells such as macrophages,
DCs and neutrophils can also express IFN-c [62].
Previous studies have shown that MDP induced NO production
in macrophages [63,64]. Several other reports also suggest a link
between Nod and NO production [64]. Our results indicating that
Nod/Rip2 signaling stimulates iNOS expression and NO
production suggest that one of the reasons why C. pneumoniae lung
infection proves lethal to most Rip2
2/2 mice is because they fail to
generate an effective NO-mediated defense by immune effector
cells, and thus cannot eradicate the pathogen.
In addition to innate immunity, adaptive immune responses
may also directly or indirectly diminish the levels of IFN-c and IL-
12 mRNA early after infection and thus may alter the quality of
the protective host immune responses. A protective role for CD8 T
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infection in CD8
2/2 mice [11]. In MyD88
2/2 mice we observed
a delay in recruitment of CD4 and CD8 T cells into the lungs [18],
while in the current study with Rip2
2/2 mice we observed
primarily a delay CD4 T cell recruitment initially followed by
significant increases in the presence of both CD4 and CD8 T cells
later on day14 (Figure S5).
Our data with bone marrow chimeric mice clearly demonstrate
that the cells responsible for Nod/Rip2-dependent defense against
C. pneumoniae are hematopoietic in origin, and are not resident
stromal cells. Additionally, adoptive transfer of WT macrophages
was able to rescue the bacterial clearance defect in Rip2
2/2 mice.
While our data do not completely rule out a potential role for
other cell types during C. pneumoniae infection, the bactericidal
effects of the Nod/Rip2 pathway appear to be predominantly of
bone marrow origin with macrophages playing the largest role.
C. pneumoniae-induced IL-12p40 production in vivo involves both
MyD88-dependent and MyD88-independent pathways [59],
suggesting a TLR-independent, but Nod-dependent mechanism
of recognition and activation. Indeed, recent studies suggest that in
endothelial cells, Nod1 plays an important role in triggering C.
pneumoniae-mediated inflammatory responses [47], and that Nod1
is involved in NF-kB activation by Chlamydia in epithelial cell
lines [56]. Furthermore, a recent study by Buchholz et. al.
concluded that C. trachomatis induced IL-8 responses are dependent
on Nod1 and Rip2 signaling in Hela cells [65]. Our in vivo data
showing that C. pneumoniae induced chemokine production in the
lungs depends on Rip2 signaling is consistent with the in vitro
observations by Buchholz et. al. These findings suggest that PGN
fragments are synthesized by chlamydiae and are recognized by
the host innate immune system. The genome sequence revealed
that Chlamydophila is actually equipped with a full complement of
PGN synthesis genes [66]. Chlamydia is sensitive to antibiotics like
penicillin that inhibit PGN synthesis [67,68], but clear-cut
biochemical evidence for the synthesis of PGN in chlamydiae is
missing [69,70]. A recent study revealed the biochemical capacity
of C. trachomatis to synthesize m-DAP and that the m-DAP
synthesis genes are expressed as early as 8h after infection [71].
This paradox, known as the ‘chlamydial anomaly’ is still being
debated in the light of genomic information [72]. However, prior
studies and our current data suggest that chlamydial PGN released
by bacteria must make their way across the inclusion membrane
into the cytosol. One potential mechanism by which this could
occur is through the proposed type III secretion system [73]. A
similar mechanism of type IV secretion has been proposed for
Nod1 signaling in H. pylori infection [55]. While the exact ligand(s)
of C. pneumoniae detected by the Nod are yet to be identified, our
data clearly indicate that both Nod1 and Nod2 recognize C.
pneumoniae and play an essential role in host defenses against this
microorganism. Our data differ from those obtained in experi-
mental infections with C. trachomatis or C. muridarum genital tract
infection, where Nod1 deficiency had no significant effect on the
efficiency of infection, or pathology in vaginally infected mice,
while Rip2-deficient mice had only slightly increased bacterial
load and delayed bacterial clearance and mildly increased oviduct
inflammation [56]. Such differences are not surprising, as the two
organisms display only 5 and 10% homology at the DNA and
protein levels, respectively, as also reflected in the different
pathobiologies they cause [74].
In summary, we demonstrate that the Nod cytosolic pattern
recognition receptors are essential for mounting an adequate
defense against C. pneumoniae, that Nod stimulate chemokine and
cytokine production and neutrophil recruitment in the early phase
of infection, and that the cells responsible for the effects of Nod are
bone marrow-derived cells, not stromal cells. Furthermore, we
show that Nods stimulate IL12-p40, IFN-c, iNOS and NO
expression, and that these factors are key for surviving the
infectious challenge. Since the TLR/MyD88 pathway is also
critically involved in detecting and eradicating C. pneumoniae, our
data highlight an emerging theme in host defenses: that divergent
pattern recognition receptors that are seemingly unrelated and
expressed in distinct compartments can nevertheless direct
cooperative responsesthat successfully combat invasion by common
pathogens such as C. pneumoniae. Coordinated and sequential
activation of TLR and Nod signaling pathways may be necessary
for efficient immune responses and host defenses against C.
pneumoniae. While TLRs might be important for initial activation
upon Chlamydophila contact, it is likely that Nod proteins play a
role in the sequential and intracellularly triggered prolonged
activation of target cells by intracellular Chlamydophila.
Materials and Methods
Mice
Rip2
2/2 mice, backcrossed ten generation to C57BL/6, were
kindly provided by Dr. Genhong Cheng (University of California
at Los Angeles, Los Angeles, CA, USA). C57BL/6 mice and
Nod2
2/2 mice were purchased from Jackson Laboratory. Nod1
2/2
mice were kindly provided by Dr. Jeffrey Weiser (University of
Pennsylvania, Philadelphia, PA, USA). Mice were maintained under
specific pathogen-free conditions, and were used at 8–12 weeks of
age. All experiments were done according to Cedars-Sinai Medical
Center Institutional Animal Care and Use Committee guidelines.
C. pneumoniae infection
C. pneumoniae CM-1 (ATCC, Manassa, VA) was propagated in
HEp-2 cells as previously described [18]. HEp-2 cells and C.
pneumoniae stocks were determined to be free of Mycoplasma
contamination by PCR. Mice were intratracheally infected with
C. pneumoniae by inoculating 100 ml of PBS containing 1610
6 IFU
of the microorganism. Bronchoalveolar lavage fluid (BALF) was
collected with 0.5 ml of PBS containing 2mM EDTA. The lavage
fluid was centrifuged, and the supernatant was used for chemokine
and cytokine measurements. The pellet placed on glass slides, and
stained by modified Wright-Giemsa staining (Diff-Quick; Fisher
Scientific, Pittsburgh, PA, USA) to determine leukocyte subtypes
based on their cellular and nuclear morphology. Lungs were
homogenized with 1ml of sucrose-phosphate-glutamate medium
and stored at 280uC.
Bacterial quantification
To quantify C. pneumoniae progeny, HEp2 cells were inoculated
with lung specimens or cell lysates as previously described [75].
Briefly HEp2 cells were infected with diluted lung homogenates or
infected cell lysates. Cultures were centrifuged for 1h at 8006g,
fed with RPMI1640 in the presence of cycloheximide (1 mg/ml),
and incubated for 72h. Thereafter, Cells were washed with PBS,
fixed with methanol for 5 min at room temperature and stained
with FITC-conjugated Chlamydia genus-specific mAb (Pathfinder
Chlamydia Culture Confirmation System; BIO-RAD, Hercules,
CA, USA) according the manufacturer protocol. Inclusion bodies
were counted by fluorescence microscopy.
Histopathological analysis
Lungs were fixed in formalin buffer, paraffin-embedded, and
hematoxylin and eosin-stained sections were scored by a trained
pathologist blinded to the genotypes as previously described [18].
Briefly, the degree of inflammation was assigned an arbitrary score
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peribronchial, or patchy interstitial inflammation involving less
than 10% of lung volume), 2 (mild=perivascular, peribronchial,
or patchy interstitial inflammation involving 10–20% of lung
volume), 3 (moderate=perivascular, peribronchial, patchy inter-
stitial, or diffuse inflammation involving 20–50% of lung volume),
and 4 (severe=diffuse inflammation involving more than 50% of
lung volume).
Detection of chemokines and cytokines
The chemokine and cytokine concentrations in the BALF, lung
homogenates or culture supernatant were determined using by
Duoset Mouse KC, MIP-2 (R&D systems, Minneapolis, MN,
USA), OptiEIA Mouse IL-6 ELISA Set (BD Biosciences, San Jose,
CA, USA) and Mouse IFN-c ELISA, Mouse IL-12 p40 ELISA
(eBioscience, San Diego, CA, USA). The assays were performed as
described manufacturer protocol.
Flow cytometric analysis
The lymphocytic makeup in the lungs after infection were
analyzed by flow cytometry of lung homogenates. Briefly,
lymphocytes were isolated by digesting the lung tissue at 37uC for
1h with HANKS’ containing 100 mg/ml Blenzyme (Roche
Diagnostics, Indianapolis, IN, USA) and 50 units/ml DNase I
(Roche Diagnostics) and filtering through a 70 mm cell strainer (BD
Biosciences). Erythrocytes were depleted by lysis buffer before
staining. Isolated single cells were stained with following specific
mAbs; CD16/32 (clone 93), Gr1 (clone RB6-8C5), CD11b (clone
M1/70), F4/80 (clone BM8), CD11c (clone HL3), CD45 (clone 30-
F11), CD4 (clone RM4-5) and CD8 (clone 53-6.7) were purchased
from eBioscience as direct conjugates to FITC, PE or PECy5. Anti
SP-C polyclonal Ab and PEcy5-conjugated donkey anti-Goat IgG
F(ab’) were used for Alveolar type II epithelial (ATII) cell staining
(Santa Cruz Biotechnology, Santa Cruz, CA, USA). Cells were
identified based on expression of following antigens: pulmonary
macrophages (F4/80+ and CD11c+), DC (F4/802 and CD11c+),
Neutrophils (Gr1+ and CD11b+), ATII cells (SP-C+, CD45- and
CD16/32-), T cells (CD3+), B cells (CD19+). For intracellular
Chlamydophila staining, cells were permeabilized using Cytofix/
Cytoperm kit (BD Biosciences) and stained with FITC-conjugated
anti-Chlamydia LPS mAb (Accurate Chemical and Scientific
Corporation, Westbury, NY, USA). Flow cytometric analysis was
performed by FACScan flow cytometer (BD Biosciences) and the
data was analyzed by Summit (Dako, Carpinteria, CA, USA).
RT-PCR
Total RNA was extracted from homogenized lung tissues by
RNeasey mini kit (QIAGEN, Valencia, CA, USA) following the
manufacturer’s protocol. Total RNA preparations were subjected
to reverse transcriptase-polymerase chain reaction analysis by
Total cDNA was generated using the Omniscript cDNA synthesis
kit (Qiagen), PCR analysis was performed using specific primers
for mouse iNOS (sense: 59-TGG GAA TGG AGA CTG TCC
CAG-39:antisense: 59-GGG ATC TGA ATG TGA TGT TTG-
39), 1min at 94uC , 1 min at 58uC and 2 min at 68uC.
Amplification of GAPDH served as a control.
Preparation of bone marrow–derived macrophages
(BMDM)
Femora and tibiae of mice were rinsed with cell culture
medium. Bone marrow cells were treated with red blood lysis
buffer (eBiosciences), cultured in RPMI1640 medium containing
10% FBS and 10 ng/ml M-CSF (R&D system). Medium changed
at day 3 and day 6. BMDM were harvested at day 9 and exposed
to C. pneumoniae by centrifugation at 5006g for 30 min.
Nitrite assay
Nitrite levels in the culture supernatant were determined using
the colorimetric Griess reaction (Sigma, St. Louis, MO, USA).
Absorbance was measured with a plate reader at 540 nm. The
concentration of NO2
2 was determined from standard curves
constructed with serial concentrations of NaNO2.
Generation of BM chimeric mice
Recipient WT (Ly5.1), WT (Ly5.2) and Rip2
2/2 (Ly5.2) mice
were lethally c-irradiated with 950 rads using a
137Cs c-source and
were reconstituted intravenously with 5610
6 BM cells derived
from respective donors 2–3h later. All mice were placed on Baytril
(Bayer HealthCare LLC, Shawnee Mission, KS, USA) for 2 weeks
following irradiation. 6–7 weeks after engraftment, mice were
tested by FACS analysis with FITC-conjugated Ly5.2 Ab (clone
104, eBiosciences) and PE-conjugated Ly5.1 Ab (clone A20,
eBiosciences) staining for chimerism.
Statistics
Data are reported as mean values6S.D. Statistical significance
was evaluated by Student’s t test. In the case of survival study,
Statistical significance was evaluated by Fisher’s exact test. For
multiple comparison test, Statistical significance was evaluated by
one way ANOVA with Tukey’s post-hoc test.
Supporting Information
Figure S1 IL-6 and IFN-c production in Rip2
2/2 BMDM and
whole lung cells. BMDM (26105 cells) were stimulated with C.
pneumoniae (Cpn) for 24 hours. IL-6 (A) and IFN-c (B) concentra-
tion in the supernatant was evaluated by ELISA. Whole lung cells
(26105 cells) were stimulated with C. pneumonia (Cpn) for 24 hours.
IL-6 (C) and IFN-c (D) concentration in the supernatant was
evaluated by ELISA. Data shown are representative of three
independent experiments. Statistical significance was determined
by Student’s t test (*p,0.05, **p,0.01, n=3).
Found at: doi:10.1371/journal.ppat.1000379.s001 (0.32 MB TIF)
Figure S2 Reconstitution of BM chimeras. Recipient mice were
lethally irradiated and reconstituted with BM from WT or Rip2
2/2
donor mice. After 7 weeks, lungs were removed, digested with
collagenase and DNase I. Cells were stained with FITC-anti-Ly5.2
mAB and PE-anti-Ly5.1 mAb and analyzed by FACScan.
Found at: doi:10.1371/journal.ppat.1000379.s002 (0.25 MB TIF)
Figure S3 Neutrophil recruitment after WT BMDMs were
adoptively transferred into Rip2
2/2 mice. BMDMs were grown
and isolated from WT or Rip2
2/2 mice and adoptively
transferred intratracheally into the airways of WT mice or
Rip2
2/2 mice (56105/mouse) together with C. pneumoniae
(16106 IFU). BMDMs were first incubated with C. pneumoniae in
vitro for 30 minutes prior to intratracheal administration. After
3 days, lungs were collected and cells were stained with PE-anti-
GR1 mAB and PECy5-anti-CD11b mAb and analyzed by
FACScan. The percentages of gated positive cells are indicated.
Data shown are representative of two independent experiments.
Found at: doi:10.1371/journal.ppat.1000379.s003 (0.64 MB TIF)
Figure S4 Phagocytosis of labeled C. pneumoniae by BMDM is
unaffected by targeted deletion of the gene for Rip2. The bacteria
were incubated with DyLigntTM 633 NHS-Ester reagent
(Thermo Scientific, Rockford, IL, USA) for 1 hour at RT. FBS
was added to stop the reaction, washed with PBS, and centrifuged
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carefully aspirated and the bacterial pellet was resuspended in cell
culture medium. BMDMs were exposed to labelled C. pneumoniae
(solid line histogram) or vehicle control (gray-filled histogram) by
centrifugation at 5006g for 30 minutes at 4uC, then incubated for
2 hours at 37uC. MOIs of 10, 20, 40, and 80 were used.
Uninternalized bacteria were removed by incubating the cells in
Trypsin/EDTA for 10 minutes at 37uC as previously described
[75]. The cells were washed and fixed with 2% formalin/PBS, and
analyzed by FACS. The mean fluorescence intensity (MFI) and
percentage of labeled C. pneumoniae internalized cells were
indicated. Data are representative of two independent experi-
ments.
Found at: doi:10.1371/journal.ppat.1000379.s004 (0.50 MB TIF)
Figure S5 Delayed CD4 T cell recruitment to the lungs in
Rip2
2/2 mice. C. pneumoniae was inoculated intratracheally into
Rip2
2/2 and WT mice (161 06 IFU/mouse). Lungs were
removed on days 0, 3, 5, and 14 post-infection, digested with
collagenase and DNase I. Cells were stained with FITC-anit-CD4
mAb, PE-anti-CD3 mAB, and PECy5-anti-CD8 mAb, and
analyzed by FACScan. The total number of CD4
+CD3
+ (A) and
CD8
+CD3
+ (B) T cells in lungs were counted. Data shown are
representative of four independent experiments. Statistical signif-
icance was determined by Student’s t test (*p,0.05).
Found at: doi:10.1371/journal.ppat.1000379.s005 (0.15 MB TIF)
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